Skip to main content

Table 3 Direct medical costs for acute care treatment of ACLF in EUR 2002

From: Economic evaluation of the artificial liver support system MARS in patients with acute-on-chronic liver failure

 

MARS

 

Controls

 
 

Mean

SD

Mean

SD

Physician Non-ICU

760

555

509

295

Nursing Non-ICU

1332

974

892

517

Medical Care Non-ICU

959

644

824

1663

Physician ICU

366

843

124

352

Nursing ICU

1261

2909

427

1215

Medical Care ICU

2375

5478

804

2288

Drugs

1363

1960

503

665

Blood products

4086

5279

870

1896

Lab-tests

1488

812

868

569

MARS

14631

7419

0

-

Overheads

2718

1483

1722

857

Total

31539

19681

7543

6527

Total (exc. MARS)

16908

15433

7543

6527

Total/d (exc. MARS)

636

712

428

498